Nucleus DNA
Overview
Nucleus DNA is a venture capital firm investing in early-stage companies in the technology and healthcare sectors. The firm focuses on sectors such as FinTech, SaaS, AI, data, and wellness, operating in both the United States and the European Union. Nucleus DNA has made over 100 investments, committing more than $45 million to more than 25 companies, and has consulted for over 25 companies.
Investment Focus
- Early-stage companies in technology and healthcare sectors
Reach Nucleus DNA directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Nucleus DNA
What sectors does Nucleus DNA invest in?
Nucleus DNA invests in FinTech, SaaS, AI, Wellness and Data, and is based in New York, United States. Nucleus DNA is listed as a venture capital in the ConnectSafely investor database.
What stage does Nucleus DNA invest at?
Nucleus DNA backs companies at Pre-Seed, Seed, Early Stage, Series A, Series B and Growth.
Which regions does Nucleus DNA invest in?
Nucleus DNA invests across United States and European Union.
How do I contact Nucleus DNA?
Nucleus DNA's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
